Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Published

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA
Date: 2023-09-05
Source: PubMed
DOI: 10.1001/jama.2023.14530
PubMed: 37651119

Derived topics and classifications

psilocybin Depression Addiction Clinical Trial Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01 The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy2026-10-01 EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW2026-09-21 Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review2026-09-10 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis2026-08-01 Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica2026-07-29 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats2026-07-01 Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01 PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW2026-06-24 Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico2026-06-17 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization2026-05-13

Related papers

Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29